Want to see AU:NC6 full AI Analyst Report?
NC6 Stock Chart & Stats
AU$0.05
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.05
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.08
Previous CloseN/A
Volume1.00
Average Volume (3M)88.90K
Market Cap
AU$27.87M
Enterprise ValueAU$18.71M
Total Cash (Recent Filing)AU$1.33M
Total Debt (Recent Filing)AU$7.17K
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
Feb 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding409,826,900
10 Day Avg. Volume83,624
30 Day Avg. Volume88,898
Financial Highlights & Ratios
PEG Ratio-1.60
Price to Book (P/B)13.94
Price to Sales (P/S)0.00
P/FCF Ratio-9.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageDebt remains very small relative to equity in most periods, which lowers lender-related solvency pressure and preserves financial flexibility. This provides some cushion while the company funds research, product development, and efforts to establish recurring commercial sales.
Sustainable Biomaterials PositioningFermentation-produced microbial cellulose targets replacement of plant- and petrochemical-derived materials, aligning the company with the longer-term shift toward sustainable inputs. If development succeeds, this positioning could support relevance across several biomaterials markets.
Multiple Product ApplicationsDevelopment of both cellulose-based fibres and nonwoven materials creates more than one potential route to commercialization across fashion, textiles, and related uses. This application breadth could reduce dependence on a single end market as the platform develops.
Bears Say
Persistent UnprofitabilityRecurring net losses alongside negative EBIT and EBITDA show that the current operating model has not yet reached profitability. Continued losses can constrain reinvestment, weaken financial resilience, and make future growth dependent on additional funding rather than internally generated earnings.
Revenue CollapseRevenue falling to zero in the latest two annual periods indicates that commercial activity has not yet translated into a dependable sales base. Without recurring revenue, operating leverage remains weak and the company has limited evidence of sustained customer adoption or commercialization progress.
Ongoing Cash BurnNegative operating and free cash flow across every period means operations continue to consume cash rather than fund themselves. Dependence on external financing can increase funding-cycle risk and may limit the company’s ability to sustain development without further capital support.
Nanollose Ltd. News
NC6 FAQ
What was Nanollose Ltd.’s price range in the past 12 months?
Nanollose Ltd. lowest share price was AU$0.04 and its highest was AU$0.08 in the past 12 months.
What is Nanollose Ltd.’s market cap?
Nanollose Ltd.’s market cap is AU$27.87M.
When is Nanollose Ltd.’s upcoming earnings report date?
Nanollose Ltd.’s upcoming earnings report date is Feb 19, 2027 which is in 135 days.
How were Nanollose Ltd.’s earnings last quarter?
Nanollose Ltd. released its earnings results on Aug 31, 2026. The company reported -AU$0.002 earnings per share for the quarter.
Is Nanollose Ltd. overvalued?
According to Wall Street analysts Nanollose Ltd.’s price is currently Overvalued.
Does Nanollose Ltd. pay dividends?
Nanollose Ltd. does not currently pay dividends.
What is Nanollose Ltd.’s EPS estimate?
Nanollose Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanollose Ltd. have?
Nanollose Ltd. has 409,826,900 shares outstanding.
What happened to Nanollose Ltd.’s price movement after its last earnings report?
Nanollose Ltd. reported an EPS of -AU$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nanollose Ltd.?
Currently, no hedge funds are holding shares in AU:NC6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanollose Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
90.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nanollose Ltd.
Nanollose Limited is an Australian biomaterials enterprise dedicated to the research, development, and commercialization of microbial nanocellulose technology. Its product line features Nullarbor Fibre, an innovative lyocell fibre produced without relying on trees, and Jelli Grow, an eco-friendly substitute for seed germination and cultivating plants. These materials find applications across various sectors, including textiles, nonwoven fabrics, and other industries. Established in 2014, the company's headquarters are situated in Nedlands, Australia.
Technical Analysis
Orthocell Ltd
―
Tissue Repair Ltd
―
AnteoTech Ltd
―
Avecho Biotechnology Limited
―
Botanix Pharmaceuticals Limited
―